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Abstract
The epidemic of bovine spongiform encephalopathy (BSE) has led to a world-wide drop in the market for beef by-products,
such as Meat-and-Bone Meal (MBM), a fat-containing but mainly proteinaceaous product traditionally used as an animal
feed supplement. While normal rendering is insufficient, the production of biodiesel from MBM has been suggested to
destroy infectivity from transmissible spongiform encephalopathies (TSEs). In addition to producing fuel, this method
simultaneously generates a nutritious solid residue. In our study we produced biodiesel from MBM under defined conditions
using a modified form of alkaline methanolysis. We evaluated the presence of prion in the three resulting phases of the
biodiesel reaction (Biodiesel, Glycerol and Solid Residue) in vitro and in vivo. Analysis of the reaction products from 263K
scrapie infected MBM led to no detectable immunoreactivity by Western Blot. Importantly, and in contrast to the
biochemical results the solid MBM residue from the reaction retained infectivity when tested in an animal bioassay.
Histochemical analysis of hamster brains inoculated with the solid residue showed typical spongiform degeneration and
vacuolation. Re-inoculation of these brains into a new cohort of hamsters led to onset of clinical scrapie symptoms within 75
days, suggesting that the specific infectivity of the prion protein was not changed during the biodiesel process. The
biodiesel reaction cannot be considered a viable prion decontamination method for MBM, although we observed increased
survival time of hamsters and reduced infectivity greater than 6 log orders in the solid MBM residue. Furthermore, results
from our study compare for the first time prion detection by Western Blot versus an infectivity bioassay for analysis of
biodiesel reaction products. We could show that biochemical analysis alone is insufficient for detection of prion infectivity
after a biodiesel process.
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Introduction
Bovine spongiform encephalopathy (BSE) belongs to the trans-
missible spongiform encephalopathies (TSEs), a family of fatal
neurodegenerative diseases. Besides BSE in cows (‘mad cow disease’),
other TSEs include Chronic Wasting Disease (CWD) in elk and deer,
Creutzfeldt-Jacob Disease (CJD) in humans and scrapie in sheep.
The hallmark of TSEs is the conversion of cellular prion protein
(PrP
c) to an abnormal isoform (prion, PrP
sc) relatively rich in beta
sheet structure [1]. It is generally recognized that PrP
sc itself is the
infectious agent responsible for onset of disease [2]. Both PrP
isoforms are encoded by the same gene, exhibit the same amino
acid sequence but differ in conformation [3].
Insolubility and protease resistance is used to distinguish PrP
sc
from PrP
c biochemically. Limited proteolysis of PrP
sc by
proteinase K but not PrP
c produces a smaller protease resistant
residue of approximately 142 amino acids that can be detected by
Western Blot [4]. Importantly, this molecular weight difference
can only be used as surrogate marker. The absence of the
described characteristics does not exclude infectivity.
Unlike viruses, prions are infectious proteins and transmissibility
is not dependent on nucleic acid [5]. Furthermore, prions are
remarkably resistant to standard decontamination procedures that
are usually used to degrade viruses and bacteria including
irradiation, boiling, dry heat and most chemicals. Decontamina-
tion of prions is especially difficult and expensive and poses
challenging problems in a large scale format such as would be
required in slaughterhouses. Inactivation of prions can be achieved
by steam autoclaving at temperatures greater than 121uC and
prior treatment with 1M NaOH, or by boiling in 1M NaOH [6,7],
techniques not suitable for large amounts of material.
Another defining characteristic of TSEs is transmissibility
between individuals or across species [8,9]. Inter-species transmis-
sion with unintentional application of incomplete inactivation
procedures is thought to be responsible for the outbreak of the
BSE epidemic in Europe. Specifically, BSE has been traced to
Meat-and-Bone Meal (MBM) derived from scrapie contaminated
sheep offal. [10]. MBM, a high protein meal, is produced through
rendering of animal carcasses after the valuable tissue parts have
been harvested in slaughterhouses [11]. MBM has been
traditionally used as an animal feed supplement, but the use has
been suspended in Europe due to food safety and health concerns
for consumers [12,13]. In the United States, where the incidence
of BSE has been very low, ruminant-derived MBM is only used as
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to better utilize beef coproducts such as MBM that accumulate in
huge amounts during the processing of cattle in slaughterhouses.
Production of biodiesel from animal fat has been proposed to
decontaminate any potential prion infectivity present in the
biodiesel [15]. Production of biodiesel from MBM can produce
a valuable fuel and a nutritious solid MBM residue that could be
used as feed additive. The production and use of fatty acid methyl
esters (FAME) as a fuel for diesel engines is a rapidly growing
technology that has penetrated the transportation fuels sector in
Europe and is in the process of doing so in the U.S. and other
countries. Compared to petroleum-derived diesel fuel biodiesel
offers advantages such as reduced emissions, domestic sourcing
and renewability [16].
In our study we produced biodiesel from MBM spiked with
263K scrapie, a model for TSE infectivity, using in situ alkaline
methanolysis with 0.25% sodium methoxide. This represents a low
cost method suitable for biodiesel production from MBM. In situ
transesterification has been described previously to be generally
applicable for FAME synthesis from lipid-bearing materials such
as MBM [17].
We validated biodiesel production from MBM by gas
chromatography and evaluated all three phases derived from the
reaction (Biodiesel, Glycerol and Solid MBM Residue) for the
presence of proteinase K resistant prion biochemically and prion
infectivity by animal bioassay.
Results
Low temperature alkaline methanolysis of MBM leads to
efficient biodiesel production
MBM entirely derived from cattle bones and offal was spiked
with 5% brain homogenate from either normal or 263K scrapie
infected hamsters, and then subjected to alkaline methanolysis.
The reaction was performed by vigorous shaking of MBM in
0.25% sodium methoxide for 2 hours at 35uC. After settling of the
mixture overnight we could distinguish 3 independent reaction
phases. The upper phase, representing the potential biodiesel, was
separated and analyzed by gas chromatography (Figure 1).
Qualitative analysis revealed several fatty acid methyl esters that
are common constituents of biodiesel (Table 1). Furthermore the
biodiesel phase was analyzed quantitatively using internal
deuterated standards (Table 2). Taken together these data show
that we efficiently produced biodiesel with a FAME composition
comparable to previous reported results [17]. Qualitative and
quantitative analysis together suggest reasonable purity of the
biodiesel derived from spiked MBM.
Figure 1. Low temperature alkaline methanolysis leads to efficient biodiesel production from MBM spiked with 5% hamster brain.
After alkaline methanolysis of MBM the upper biodiesel phase was separated and analyzed by GC-MS. GC-MS results show the alkaline methanolysis
reaction produced various fatty acid methyl esters (FAME) which are typical components of biodiesel (see Table 1 for FAME composition). The two
most abundant fatty acid methyl esters were analyzed quantitatively by using internal deuterated standards and calibration curve (Table 2).
doi:10.1371/journal.pone.0002969.g001
Table 1. Alkaline methanolysis reaction produced various
fatty acid methyl esters which are typical components of
biodiesel
*
1 Tetradecanoic acid methyl ester
2 Pentadecanoic acid methyl ester
3 Hexadecenoic acid methyl ester
4 Hexadecanoic acid methyl ester
5 Heptadecanoic acid methyl ester
6 Octadecadienoic acid methyl ester
7 Octadecenoic acid methyl ester
8 Octadecanoic acid methyl ester
*Numbers indicate the spikes shown in Figure 1
doi:10.1371/journal.pone.0002969.t001
Table 2. Quantification of the two most abundant fatty acid
methyl esters using internal deuterated standards*
Fatty Acid Methyl Ester (FAME)
Percentage of
total FAME produced
Stearate (Octadecanoic acid methyl ester) 20%
Palmitate (Hexadecanoic acid methyl ester) 17%
*calculated according to Haas et al.
doi:10.1371/journal.pone.0002969.t002
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are not toxic
In order to validate the infectivity of the three different resulting
phases from the biodiesel reaction we needed to perform an in vivo
assay in Syrian hamsters that involved intracranial inoculation (ic)
of the generated material [18]. First we evaluated biodiesel
reaction fractions from MBM spiked with 5% uninfected brain
(MBM c) for potential toxic effects in our animal bioassay. This
was necessary to exclude death of animals due to acute toxicity
from inoculation of biodiesel, glycerol or the solid MBM residue
and not due to scrapie infectivity. The 3 reaction phases were
diluted 1:10
3 and 1:10
4 into 320 mM sucrose and 50 ml of each
sample was inoculated into Syrian hamsters (Figure S1 and Table
S1). Animals were monitored closely over 72 hours. No acute toxic
effects of the inocula were observed and all animals survived
treatment. The study was terminated by sacrificing the hamsters
after 90 days. We also analyzed the inocula (as diluted) via
Western Blot. Interestingly we could not detect PrP in the
inoculated phases, suggesting destruction of proteinaceaous
material by alkaline methanolysis. Normal brain homogenate
and MBM c served as positive control. PrP was clearly visible at the
expected molecular weight in these control samples (Figure S1).
Solid MBM residue from biodiesel reaction retains
infectivity
In order to investigate the decontamination potential of the
biodiesel reaction under our defined conditions we performed
alkaline methanolysis on MBM spiked with 5% 263K scrapie
infected brain (MBM sc). After the reaction the three chemical
phases were separated and each phase was subsequently diluted to
an estimated amount of 25 mg of total protein into 50 mlo f
320 mM sucrose solution to prepare a homogeneous sample for
intracranial (ic) inoculation. The calculation of total protein was
based on the input of brain equivalent before reaction and the
assumption that all proteinaceaous material partitioned into the
respective phase. Samples were divided and either inoculated into
Syrian hamsters or analyzed by Western Blot for presence of PrP
sc.
We prepared an identical sample set performing alkaline
methanolysis on MBM c as negative control for in vitro and in
vivo experiments.
Western analysis. First we performed Western Blots on the
crude fractions from the reaction as well as on the above described
inocula (Figure 2). Western Blot results show no PrP detected in any
of the 3 phases produced by the reaction (crude) or in the inoculum.
After proteinase K digestion PrP
sc was clearly detected in MBM
spiked with infected brain but not subjected to the reaction (MBM
sc crude), as expected. Notable here is that we could not detect any
protease resistant material in the corresponding inoculum at this
dilution by Western Blot (MBM sc inoculum). 1% NBH served as a
control, displaying a slightly higher molecular weight, since it was
not digested by proteinase K (Figure 2). These data demonstrate
that alkaline methanolysis decreased the amount of PrP
sc below the
detection limit of Western Blot in the biodiesel, glycerol, and solid
MBM residue phase.
Infectivity bioassay. To confirm our results obtained by
Western Blot we used a hamster bioassay to assess prion infectivity
in all three reaction phases. Syrian hamsters were inoculated with
biodiesel, glycerol or solid MBM residue produced from either
MBM sc or uninfected MBM c (negative control). Furthermore, we
inoculated untreated MBM c and MBM sc as pre-reaction controls.
A group of hamsters inoculated with 1% scrapie brain homogenate
served as additional control to prove the integrity of our animal
assay (Table 3). These animals showed clinical scrapie symptoms
around 65 days after inoculation and were sacrificed after 75 days,
which is comparable to previous described results [19] Animals
inoculated with a suspension of MBM sc began to display clinical
symptoms around 75 days post inoculation and were sacrificed
when moribund. Three animals from this group died after only 45
days,butdeathwasapparentlynot duetoscrapie,asthe animalsdid
not exhibit typical scrapie symptoms (Figure 3, Table 3).
Most interestingly, all animals inoculated with the solid MBM
residue produced by the reaction with scrapie brain spiked MBM
developed disease (Table 3: Solid MBM Residue +5% infected
brain;Figure3:SolidMBMResiduesc),eventhoughnoPrP
sccould
be detected pre-inoculation by Western Blot (Figure 2: Solid MBM
Residue sc). These results show that our biodiesel method failed to
completely destroy infectivity in the solid MBM residue but reduced
infectivity by approximately six log orders (166+/213 days).
No animals inoculated with biodiesel or glycerol fractions derived
from infected MBM (Biodiesel sc, Glycerol sc) died with scrapie
symptoms. The 28% loss of animals in these groups is comparable
to previous reported attrition during long-term experiments.
Secondary passage of brain homogenate from these animals was
free of scrapie infectivity (survival.200 days). A minor loss of
animals in the negative control groups was not due to scrapie
infectivity, but rather to traumatic injuries from fighting (Table S2).
Endpoint Western analysis. After termination of the animal
bioassay we performed Western Blot analysis of select brains from
animals from the different treatment groups to determine the
Figure 2. Western blot analysis of reaction products from MBM spiked with 5% scrapie brain. We performed alkaline methanolysis on
scrapie brain spiked MBM as described under Methods and analyzed the reaction products as well as the inoculation samples by Western blot using
monoclonal (mAb) 3F4. Results show no PrP detected in any of the 3 phases produced by the reaction (crude), nor in the inoculum we subsequently
prepared by diluting each phase to 25 mg of total brain equivalent protein into 50 ml of 320 mM sucrose. After proteinase K digestion PrP
sc was
clearly detected in MBM spiked with infected brain but not subjected to the reaction (MBM sc, crude +PK). 1% NBH served as a control, displaying a
slightly higher molecular weight, since it was not proteinase K digested.
doi:10.1371/journal.pone.0002969.g002
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support of the bioassay we were able to detect PrP
sc in brain
homogenates prepared from animals that had been inoculated
with the Solid MBM Residue sc, despite the absence of detectable
PrP
sc in the inoculum. Brains from animals inoculated with
untreated MBM sc (positive control) also contained PK resistant
material (Figure 4A). PrP
sc was undetectable in Biodiesel sc or
Glycerol sc by Western Blot or bioassay (Figure 4B). None of the
uninfected negative controls showed protease resistant PrP, as
expected (Figure 4A and B).
These data show that the production of biodiesel and glycerol
from prion contaminated MBM led to no detectable PrP
sc or prion
infectivity in the applied assays. In contrast, the solid MBM
residue retained infectivity in the animal bioassay and cannot be
considered as decontaminated and thus could still serve as a vector
for disease transmission.
Brains from animals inoculated with solid MBM residue
show typical spongiform degeneration and vacuolation
To confirm scrapie brain pathology from animals with clinical
scrapie symptoms we evaluated brain sections counterstained with
Hematoxylin-Congo red. Typical vacuolation of prion disease was
observed in brain sections from animals inoculated with the Solid
MBM Residue sc (Figure 5C and D). Control animals inoculated
with the Solid MBM residue resulting from the reaction with
MBM+5% uninfected brain (Solid MBM Residue c) exhibited
normal brain morphology without vacuolation (Figure 5A and B).
Biodiesel process does not change the specific infectivity
of the prion protein
Secondary passage of brain homogenates was conducted from
animals in all reaction groups. Brain homogenates from animals
that received Solid MBM Residue sc, MBM sc and Biodiesel sc
and Glycerol sc were inoculated into new groups of hamsters to
assess results from the initial bioassay. Animals that received
inocula prepared from brains that were treated with Solid MBM
Residue sc and MBM sc developed clinical scrapie symptoms at 70
days and were sacrificed at 80 days (data not shown). This
confirms that MBM sc can transmit scrapie following alkaline
methanolysis. Survival time after re-inoculation was comparable to
the survival time after inoculation of a standard 1% scrapie brain
homogenate (Figure 3A). These data suggest that the biodiesel
process did not change the specific infectivity of the prion protein.
Animals that received inocula prepared from Biodiesel sc or
Glycerol sc brains did not exhibit scrapie symptoms and survived
at least 200 days, confirming that the biodiesel and glycerol phase
showed no detectable prion protein infectivity after the process.
Discussion
Decontamination of pathogenic prions has turned out to be a
challenging endeavor. Prions are known to be unusually resistant to
commondecontaminationmethods.BSEisbelieved tobe a resultof
insufficient decontamination and rendering methods of ruminant
coproducts that were used as animal feed. Although this led to a
devastating feed-borne epidemic among cattle, a major concern
here is the overwhelming evidence for the zoonotic transmission of
bovine prions to humans [20]. Total elimination of TSEs requires
methods that completely destroy any potential prion infectivity in a
large scaleformat. Production ofbiodieselfrom bovine fatandbrain
tissue has been proposed to be a useful tool for decontamination of
prions resulting in safe biodiesel [21]. In our study we evaluated an
inexpensive large scale method (in situ transesterification) for
production of biodiesel for TSE decontamination potential.
Furthermore we investigated potential infectivity present not only
in the biodiesel but also in the two other phases developed from the
process, a solid MBM residue and glycerol. The solid MBM residue
is of particular interest for its potential as a nutritious feed additive
for ruminants such as cattle. In our hands, under optimal conditions
for transesterification, the solid MBM residue retained 7% of the
initial triglyceride and 90% of the initial protein content [17]
The alkaline methanolysis method efficiently produced biodiesel
from MBM spiked with hamster brain and the method eliminated
PrP
sc detection in all products as determined by Western blot. Our
biochemical results are comparable to previous studies, at least
with regards to the biodiesel and glycerol phase [15]. Biodiesel and
glycerol products had no detectable infectivity in our long term
animal assay (survival.200d). In contrast to the biodiesel and
glycerol phase, we show that the remaining solid MBM residue
that had been spiked with scrapie brain retained infectivity in our
sensitive bioassay. All animals inoculated with the infected solid
MBM residue developed scrapie. However, increased survival time
suggests the reaction did reduce infectivity in solid MBM residue
from 10
23 ID50 to 10
29 ID50 (a partial decontamination of ,6
logs), based on a standard hamster survival curve that we
established in our laboratory according to previous reported
results [18]. The broad distribution of time-to-death for these
animals is likely due to uneven distribution of infectious material in
the inoculum, as the residue produced a relatively coarse
suspension in the syringe. We suggest that, in addition to
disinfection by the alkaline methanolysis reaction, we observe
significant partitioning of infectivity, from the liquid phases into
the solid residue. Another possible explanation for increased
survival of animals inoculated with the solid MBM residue could
be a high binding affinity of the prion protein to MBM and thus a
sustained release from MBM in the brain. A phenomenon like this
was described previously for prion binding to soil minerals [22]. In
our study, when spiked into MBM, PrP
sc was only detectable by
Western Blot after boiling of sample in detergent. On the other
hand we could show that control animals that received infected
MBM not subjected to the reaction (MBM sc) developed disease in
a time frame comparable to a standard scrapie brain homogenate.
Our results clearly show that Western Blot detection alone is
insufficient to conclude on the absence of infectious prion,
particularly when assessing a grossly heterogeneous sample such
as MBM. This study illustrates that lack of prion detection in vitro
does not necessarily exclude infectivity as determined by bioassay.
Table 3. Solid MBM Residue remains infectious after alkaline
methanolysis.
Inoculum





Biodiesel phase 4/14 ** .200




MBM+5% brain 8/8 *** 72+/28*
Brain Homogenate 1% 6/6 *** 75
*mean+/2standard error
**unsacrificed animals survived longer than 200 days, until study was
terminated, without clinical scrapie symptoms
***sacrificed animals exhibited clinical scrapie symptoms
doi:10.1371/journal.pone.0002969.t003
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MBM residue probably limits the use of ruminant MBM as a feed
additive to only non-ruminants, such as fish and fowl, as they are
not susceptible to TSEs. Relatively minor variations of this
reaction (e.g., more heat and/or alkali) may prove fully effective
for complete destruction of infectivity in the solid MBM residue,




Sample Preparation. 25 ml of the sample was dried under a
constant stream of nitrogen. The dried residue was reconstituted in
1.0 ml of isooctane. 1 ml of this solution was injected into the GC-
MS.
GC-MS Apparatus. The samples were analyzed using a
Hewlett Packard HP 6890 Series GC system combined with an
HP 5973 Series mass selective detector, an HP 6890 Series injector
and an HP Chem Station G1701AA version A.03.00. The MS
conditions were as follows: full scan mode; electron impact
ionization (EI) mode: ionization energy, 70 eV; ion source
temperature, 220uC; capillary direct interface heated at 260uC.
GC conditions. GC conditions were as follows: split less
injection mode; column, HP-1MS capillary (25 m_0.25 mm I.D.),
250 nmfilmthickness; injectionport temperature, 280uC;carrier gas,
helium;flowrate,0.6 ml/min;columntemperature,100uCin c re ase d
to 310uCa t3 0 uC/min, and was held at this temperature for 5 min.
Figure 3. Infectivity bioassay. (A) Control animals inoculated with 50 ml 1% scrapie BH exhibited clinical symptoms 75 days after inoculation and
were sacrificed (1% sc brain). Animals inoculated with MBM sc began to display clinical symptoms around 75 days post inoculation and were
sacrificed when moribund. All animals inoculated with Solid MBM Residue sc developed disease (166+/213 days), even though no PrP
sc was detected
by Western Blot in initial inoculum. Survival time of animals from all 3 groups was significantly shorter as compared to control animals (control: MBM
c and Solid MBM Residue c; p,0.05; ANOVA on ranks). Animals inoculated with Biodiesel sc and Glycerol sc displayed no clinical symptoms within the
time frame of the experiment (.200 days). Survival was comparable to control group animals (Biodiesel c, Glycerol c). Days of survival are calculated
as mean values. (B) The range of time-to death values of hamsters inoculated with MBM sc and Solid MBM Residue sc is summarized showing the
median, upper and lower quartiles and extreme values (outliers) for comparison of both groups.
doi:10.1371/journal.pone.0002969.g003
BD/ Infectious MBM Paper
PLoS ONE | www.plosone.org 5 August 2008 | Volume 3 | Issue 8 | e2969Source and characteristics of MBM
MBM samples were obtained through the Fats and Proteins
Research Foundation (Alexandria, VA) from an anonymous
member company. The supplier specified that the MBM was
made entirely from cattle bones and offal. The material had about
43% protein and 37% ash.
We prepared small, representative samples from this very
heterogeneous material. Initially a mortar and pestle was used to
reduce the size of the largest pieces and break up large aggregates.
Then the material was mixed well and split four times with a 10-
slot riffle box, resulting in a ,120 g representative sample. This
material was milled under liquid nitrogen in a Spex Centriprep
model 6800 mill (Spex Centiprep Inc., Metuchen, New Jersey,
United States). Milling the material into such a fine powder does
not represent industrial practice. This milling, however, was
preferable for two reasons. First, MBM is heterogeneous at a fairly
large scale; without reducing the particle size and mixing, it is
unlikely that any small sample of MBM would be representative of
the whole. Secondly, small particle size was a requirement for
injecting the particles during the bioassay. The resulting fine
powder was mixed well and split into ,10 g samples by repeated
cone-and-quartering. Samples were finally dried in a desiccator for
48 h to get rid of most of the humidity that interferes with the
biodiesel reaction (in situ transesterification).
Alkaline methanolysis
As a model for a rendered TSE-infected animal carcass we
spiked 10 g MBM with 0.5 g hamster brain, froze it with liquid
nitrogen, and homogenized the mixture using a mortar and pestle.
Alkaline methanolysis was performed by shaking the MBM/ brain
mixture vigorously in 24 ml 0.25 M sodium methoxide at 35uC
for 2 hours. The study sample was spiked with brain from a
scrapie infected hamster (263K), and an identical sample not
subjected to the reaction served as a positive control. In parallel we
performed a negative control reaction using MBM spiked with
brain from a normal/uninfected hamster.
This alternate method of biodiesel production does not require
prior lipid extraction but has been proven to convert lipids into
Fatty acid methyl esters with high efficiency [17].
Sample preparation for intracranial inoculation
(infectivity bioassay)
The in situ transesterification of lipids to FAME typically leads
to 3 different reaction phases or products which are easy to
separate. The solid MBM residue was air dried overnight and
crushed with mortar and pestle (without liquid nitrogen) to obtain
a homogeneous sample. The solid MBM residue was suspended in
320 mM sucrose to 25 mg total protein/50 ml with gentle heating
for 20 min at 40uC. The resulting non-homogenous suspension
was passed through a 20 gauge needle, and then a 27 gauge
needle, and some solid material was lost in each passage. The
biodiesel and glycerol phases were simply diluted into 320 mM
sucrose to an estimated amount of 25 mg total protein/50 ml (10-3
ID50). Under anesthesia, weanling female Syrian hamsters
received 50 ml of intracranial inoculum. Inocula for toxicity
studies were prepared as described above but reaction phases were
diluted into 320 mM Sucrose at two different concentrations
(25 mg and 0.25 mg total protein/50 ml) and only non infected
MBM was used.
Western Blotting
10% Brain homogenate was prepared at room temperature by
homogenizing 1 g hamster brain with a Polytron homogenizer in
10 ml MES extraction buffer (60 mM n-Octyl-glucoside, 1%
Triton-X 100, 25 mM MES-HCl, pH 6.5, 150 mM NaCl; all
chemicals from Sigma-Aldrich Corp., St. Louis, Missouri, United
States) containing one tablet of Roche complete mini protease
inhibitor (Roche Corp., Basel, Switzerland) and 1 mM phenyl-
methane-sulfonyl-fluoride (Sigma-Aldrich Corp.). The homoge-
nate was precleared at 3000 rpm for 5 min in a centrifuge
(Eppendorf Corp., Hamburg, Germany). The solution was diluted
1:10 in the above described MES buffer and aliquoted for further
use. For Western Blotting aliquots were loaded on a SDS-PAGE
gel at 25 mg total protein/ lane. Protein content was measured by
BCA using an Eppendorf Biophotometer.
Crude reaction fractions of biodiesel and glycerol were diluted
with 4x sample loading buffer (SLB, Invitrogen Corp., Carlsbad,
California, United States), heated to 70uC for 10 min and directly
loaded onto a precast 4–12% gradient gel (Invitrogen Corp.). The
non reacted brain spiked MBM and solid MBM residue each were
boiled for 10 min in sample loading buffer and supernatants were
taken off and analyzed by immunoblotting. Previous prepared
inocula of the respective fractions (see above) were simply diluted
and subjected to Western Blot analysis.
For detection of PrP
sc infectious samples were digested with
proteinase K solution (Roche Corp., 15 mg/ml final concentration)
for 1 hour at 60uC.
Electrophoresis was performed using an XCell SureLock Mini-
Cell (Invitrogen Corp.). Protein transfer was performed wet with a
Mini Trans-blot Cell (Bio-Rad, Hercules, California, United
States). PrP was detected using either monoclonal mAb 3F4 or
monoclonal mAb IPC1 (Sigma-Aldrich Corp.). Protein bands
Figure 4. Western Blot analysis of hamster brains after
termination of the infectivity bioassay. After the animal bioassay
was terminated we evaluated brains from the different treatment
groups for presence of PrP
sc. We could detect PrP
sc in brains from
animals treated with infected solid MBM residue (4A, Solid Residue sc,
+PK) as well as animals that received MBM spiked with infected brain
(4A, MBM sc, +PK). Samples were digested with proteinase K to verify
presence of PrP
sc and detected with monoclonal (mAb) IPC1. Brain
homogenates from inoculated biodiesel and glycerol fractions con-
tained no PK resistant material whether derived from infected or
uninfected MBM (4B). This suggests that death of animals inoculated
with the solid MBM residue was definitely due to infection with scrapie
whereas the biodiesel and glycerol phase of the reaction can be
considered as decontaminated due to lack of any detectable protease
resistant material in brains from animals injected with the respective
phases.
doi:10.1371/journal.pone.0002969.g004
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(Pierce Biotechnology Inc., Rockford, Illinois, United States) and
enhanced chemiluminescent detection (Pierce Biotechnology Inc.).
Histochemistry
Hamster brains were fixed in 10% neutral buffered formalin for
48 h then sunk in 30% sucrose. Coronal cryosections (5 mm) were
serially collected, attached to glass slides, counterstained with
Meyer’s hematoxylin and Congo Red. Sections were evaluated on
an inverted Leica DMI4000B microscope and digital images
collected using an attached Leica DFC320 camera.
Cryo-sections were prepared from animals sacrificed 150 days
post-inoculation, when the infected animal displayed severe
scrapie symptoms.
Supporting Information
Figure S1 Acute toxicity studies. To evaluate the acute toxicity
and tolerable dose of the products of the biodiesel process, we
performed Western blot and intracranial inoculation in hamsters
using the reaction products from uninfected brain, after dilution of
the 3 product phases (25 mg and 2.5 mg protein in 50 ml
respectively). Western blot analysis (upper phase (Biodiesel c)
lanes 2 and 3; interphase (Glycerol c), lanes 4 and 5; and lower
phase (Solid MBM Residue c), lanes 6 and 7) failed to detect PrP in
any inoculum. MBM spiked with 5% brain (MBM c, lanes 8-10,
25 mg, 2.5 mg and 0.25 mgi n5 0ml respectively) and uninfected/
normal brain homogenate (1% NBH, lane 1) served as controls.
Coomassie stain (data not shown) showed a smear of protein
present in all fractions except the upper phase (Biodiesel c),
indicating the presence of proteinaceous material.
Found at: doi:10.1371/journal.pone.0002969.s001 (0.20 MB TIF)
Table S1
Found at: doi:10.1371/journal.pone.0002969.s002 (0.03 MB
DOC)
Table S2
Found at: doi:10.1371/journal.pone.0002969.s003 (0.03 MB
DOC)
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